• EI
  • Scopus
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
  • DOAJ
  • EBSCO
  • 北大核心期刊
  • 中国核心学术期刊RCCSE
  • JST China
  • FSTA
  • 中国精品科技期刊
  • 中国农业核心期刊
  • CA
  • WJCI
  • 中国科技核心期刊CSTPCD
  • 中国生物医学SinoMed
中国精品科技期刊2020
王若诚, 辛瑜, 张梁. 鲎素Tachyplesin Ⅰ在大肠杆菌中的重组表达及其抑菌活性[J]. 食品工业科技, 2020, 41(19): 94-98. DOI: 10.13386/j.issn1002-0306.2020.19.015
引用本文: 王若诚, 辛瑜, 张梁. 鲎素Tachyplesin Ⅰ在大肠杆菌中的重组表达及其抑菌活性[J]. 食品工业科技, 2020, 41(19): 94-98. DOI: 10.13386/j.issn1002-0306.2020.19.015
WANG Ruo-cheng, XIN Yu, ZHANG Liang. Recombinant Expression of Tachyplesin Ⅰ in E.coli and Its Antibacterial Activity[J]. Science and Technology of Food Industry, 2020, 41(19): 94-98. DOI: 10.13386/j.issn1002-0306.2020.19.015
Citation: WANG Ruo-cheng, XIN Yu, ZHANG Liang. Recombinant Expression of Tachyplesin Ⅰ in E.coli and Its Antibacterial Activity[J]. Science and Technology of Food Industry, 2020, 41(19): 94-98. DOI: 10.13386/j.issn1002-0306.2020.19.015

鲎素Tachyplesin Ⅰ在大肠杆菌中的重组表达及其抑菌活性

Recombinant Expression of Tachyplesin Ⅰ in E.coli and Its Antibacterial Activity

  • 摘要: 为了高效制备抗菌肽,本文将鲎素抗菌肽目的基因Tachyplesin-1(TP1)在大肠杆菌BL21中进行表达。首先构建表达质粒pET32a-TP1并转化大肠杆菌BL21(DE3),在IPTG诱导下进行目的融合蛋白表达,并利用His标签与镍柱亲和层析对融合蛋白进行纯化。纯化后的融合蛋白经羟胺裂解液切割和质谱分析后,获得单一的TP1重组蛋白,最后对其抑菌活性进行表征。结果表明,重组菌在37℃经IPTG诱导后,融合蛋白表达成功,TrxA-TP1融合蛋白的分子量在20 kDa左右。经羟胺裂解得到的重组蛋白TP1对于金黄色葡萄球菌(Staphylococcus aureus)与枯草芽孢杆菌(Bacillus subtilis)均具有良好抑菌活性,最小抑菌浓度分别为6和10 mg/L。本研究为鲎素抗菌肽TP1的开发应用和大量生产奠定了基础。

     

    Abstract: In order to obtain antimicrobial peptide efficiently,the recombinant expression of antimicrobial peptide target gene Tachyplesin Ⅰ(TP1)in Escherichia coli BL21(DE3)was studied. The expression vector pET32a-TP1 was constructed and converted to Escherichia coli BL21(DE3). IPTG induced the expression of target genes,and the fusion protein was purified by NI-NTA affinity chromatography. The purified TrxA-TP1 fusion peptide was released by hydroxylamine and recombinant TP1 was analyzed by mass spectrometry. Results showed that TrxA-TP1 fusion protein was induced successfully with IPTG at 37℃. The molecular weight of TrxA-TP1 was about 20 kDa. The recombinant TP1 obtained by hydroxylamine cleavage showed strong antibacterial bioactivity against S.aureus and B.subtilis,The minimal inhibitory concentration was 6 and 10 mg/L respectively. These experiments established a useful system for further studies,application and mass production of antimicrobial peptide TP1.

     

/

返回文章
返回